Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Hagens Berman / Revolution Medicines

Hagens Berman & Revolution Medicines

2 shared events · Importance 3 · Last updated Aug 04, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
65
Regulatory
Erasca Faces Securities Fraud Lawsuits
Hagens Berman: Hagens Berman is a shareholder rights law firm investigating and filing class action lawsuits against Erasca for alleged securities law violations.
Revolution Medicines: Revolution Medicines is the company that accused Erasca of patent infringement and trade secret misappropriation related to Erasca's ERAS-0015, claiming improper comparisons to its own drug candidate RMC-6236. This action has negatively impacted Erasca.
May 19, 2026 · 323 articles
46
Regulatory
Erasca Securities Fraud Class Action
Hagens Berman: Hagens Berman is investigating the securities fraud claims and representing investors. The firm is actively seeking lead plaintiff role.
Revolution Medicines: Revolution Medicines is the competitor whose patent and trade secret claims against Erasca triggered the stock drop. The allegations could strengthen its competitive position in the RAS-targeting space.
Jun 11, 2026 · 193 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Hagens Berman and Revolution Medicines interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.